Scorpius Holdings, Inc., a pharmaceutical company based in North Carolina, with a current market capitalization of $1.14 million and trailing twelve-month revenue of $10.04 million, has entered into a ...

Treats are in store for stargazers at both ends of the short summer nights this June. Evenings belong to Saturn, a beacon in the southwest. Not sure which object is the ringed planet? Look the ...

A stellar nursery hidden in Scorpius, the Dark Tower is a glowing, wind-sculpted cloud of gas shaped by young stars’ ...

Scorpius Holdings, Inc., a pharmaceutical company with a market capitalization of $1.36 million, has entered into a material definitive agreement through the issuance of a non-convertible promissory ...

Partnership highlights Scorpius’ expertise in supporting innovative therapeutic programsDURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) ...

Scorpius Holdings, Inc. DURHAM, N.C., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and ...

From vivid nebulae to a comprehensive view of our evolving universe, check out these 7 amazing deep-field images captured by ...

Scorpius announced its collaboration with KaloCyte. Under this initial project, Scorpius will utilize its scientific and technical expertise to ...

Scorpius Holdings said it will sell 29.4 million shares of its common stock for 34 cents apiece, as it reiterated its going-concern warning. The contract development and manufacturing company said ...

DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American:SCPX) (“Scorpius” or “the Company”), an integrated contract development ...

And now, following up on Ed Brisson's ThunderCats: Apex, with the new character Scorpius. ThunderCats Lost #2 features covers by Declan Shalvey, Clayton Henry, Meghan Hetrick, Mark Bagley ...

Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer.